Pullman, Washington
May 15, 2003

Aleurone Corporation today announced the completion of a licensing agreement with Ventria Bioscience for its use of Aleurone’s patented agricultural biotech/genetic engineering technology, which covers any cereal plant that expresses a foreign protein predominantly in the endosperm. It is anticipated that the technology would be applicable for genetic engineering of a variety of
improvements in the nutritional qualities of cereal grains for both animals and humans, and for use of cereal grains as factories for production of commercially valuable proteins, including industrial
enzymes and pharmaceuticals.

Under the terms of the agreement, Aleurone will receive up-front funds as well as future royalties on products  produced with the technology.

Aleurone exclusively licensed U.S. patent 5,677,474 from Washington University in St. Louis in January, 1988.